These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27092633)

  • 1. How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity.
    Krasniqi V; Dimovski A; Domjanović IK; Bilić I; Božina N
    Arh Hig Rada Toksikol; 2016 Mar; 67(1):1-8. PubMed ID: 27092633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism.
    Lazarska KE; Dekker SJ; Vermeulen NPE; Commandeur JNM
    Toxicol Lett; 2018 Mar; 284():70-78. PubMed ID: 29203276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
    Agúndez JA; García-Martín E; Martínez C
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):607-20. PubMed ID: 19422321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cytochrome P450 isoforms involved in sequential two-step bioactivation of diclofenac to reactive p-benzoquinone imines.
    den Braver MW; den Braver-Sewradj SP; Vermeulen NP; Commandeur JN
    Toxicol Lett; 2016 Jun; 253():46-54. PubMed ID: 27130197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.
    Ochoa D; Prieto-Pérez R; Román M; Talegón M; Rivas A; Galicia I; Abad-Santos F; Cabaleiro T
    Pharmacogenomics; 2015; 16(9):939-48. PubMed ID: 26122864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of residues 286 and 289 as critical for conferring substrate specificity of human CYP2C9 for diclofenac and ibuprofen.
    Klose TS; Ibeanu GC; Ghanayem BI; Pedersen LG; Li L; Hall SD; Goldstein JA
    Arch Biochem Biophys; 1998 Sep; 357(2):240-8. PubMed ID: 9735164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of mitochondrial dysfunction, cytochrome P450 activity, and active transport in the toxicity of structurally related NSAIDs.
    van Leeuwen JS; Unlü B; Vermeulen NP; Vos JC
    Toxicol In Vitro; 2012 Mar; 26(2):197-205. PubMed ID: 22138569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism related toxicity of diclofenac in yeast as model system.
    van Leeuwen JS; Vredenburg G; Dragovic S; Tjong TF; Vos JC; Vermeulen NP
    Toxicol Lett; 2011 Feb; 200(3):162-8. PubMed ID: 21111035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen.
    Wade LT; Kenna JG; Caldwell J
    Chem Res Toxicol; 1997 May; 10(5):546-55. PubMed ID: 9168252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine.
    Zhu Y; Zhang QY
    J Pharmacol Exp Ther; 2012 Nov; 343(2):362-70. PubMed ID: 22892338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
    Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
    Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
    van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
    Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individuals with CYP2C8 and CYP2C9 reduced metabolism haplotypes self-adjusted ibuprofen dose in the Coriell Personalized Medicine Collaborative.
    Zajic SC; Jarvis JP; Zhang P; Rajula KD; Brangan A; Brenner R; Dempsey MP; Christman MF
    Pharmacogenet Genomics; 2019 Apr; 29(3):49-57. PubMed ID: 30562214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
    Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR
    Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of non-steroidal anti-inflammatory drugs (NSAIDs) by Streptomyces griseolus CYP105A1 and its variants.
    Yogo Y; Yasuda K; Takita T; Yasukawa K; Iwai Y; Nishikawa M; Sugimoto H; Ikushiro S; Sakaki T
    Drug Metab Pharmacokinet; 2022 Aug; 45():100455. PubMed ID: 35617891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants.
    Hiratsuka M
    Biol Pharm Bull; 2016; 39(11):1748-1759. PubMed ID: 27803446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.